Google Übersetzer
Atyr Pharma, Inc.
About
0.53USD+0.05 +9.86%
Closed • Updated at 07:45 GMT+00:00Market Cap$52.03M
Volume3.41M
Beta1.06
RSI39.39
Gross Margin-723.16%
Atyr Pharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May 13 2026
aTyr Pharma to Participate in Upcoming Investor Conferences
May 11 2026
aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
Mar 5 2026
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Feb 3 2026
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Recent Videos
ATYR Stock TOMORROW UPDATE! (The Exact Answer) aTyr Pharma stock analysis today
May 19, 2026
aTyr Pharma Surges 32% on Efzofitimod Update – FDA Feedback & IND June 2026
May 17, 2026
aTyr Pharma Surges 32% on Efzofitimod Update – FDA Feedback & IND June 2026
May 17, 2026
aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis
May 12, 2026